Stroke, which occurs when a blood vessel supplying the brain is blocked and neurons die, is one of the leading causes of disability. Statistics show that 1 in 6 people are at risk of having a stroke at some point in their lives.
The human brain is the most complex organ in our body, granting us the ability to speak, form memories, and engage in abstract thought. However, this complexity comes at a cost: brain tissue has a very limited capacity for regeneration. Unlike the skin or the liver, dead neurons rarely regenerate, which is why brain damage is often the starting point for many age-related diseases, including stroke.
In the most common form of stroke, ischemic stroke, blood flow to an area of the brain is cut off. Although medical advances have improved survival rates, there is currently no treatment that can repair the neuronal damage caused by stroke. Rehabilitation partially restores function, but many survivors are left with permanent motor and cognitive impairments.
Over the past decades, cell therapy has opened up new avenues in regenerative medicine. The goal of these therapies is to replace or ‘repair’ damaged tissue by introducing new cells that can survive, mature, and perform lost functions.
A significant precedent in this field was set in Sweden in the late 1980s, when researchers successfully transplanted neural stem cells into patients with Parkinson’s disease. Replacing the damaged neurons restored motor function for more than a decade in many patients. This was the first solid evidence that it is possible to restore human brain function using living cells.
While this success was inspirational, stroke presents different challenges:
-
The scale of the damage: Ischemic damage is typically more extensive.
-
The diversity of damaged cells: Not just one cell type is affected, but multiple populations of neurons, glial cells, and blood vessels are damaged.
-
Functional integration: It is not enough for the transplanted cells to survive. They must functionally integrate, meaning they need to send out their axons (the extensions that transmit nerve impulses) and form appropriate synapses with the surviving neurons. This is similar to restoring traffic over a collapsed bridge: the connections must be established correctly to ensure the flow of information.
To overcome this unique challenge, scientists are employing genetic engineering, one of modern biology’s most revolutionary technologies. It allows for the modification of cells in a way that makes them more effective and better able to integrate into the damaged tissue.
For instance, researchers can incorporate a gene into the transplanted cells that codes for the BDNF (Brain-Derived Neurotrophic Factor) protein. This neurotrophic factor promotes brain development and enhances the growth of axons and the formation of synapses. The goal of this approach is to facilitate the functional integration of new neurons into the damaged brain, a crucial step for the transplant to not only fill a void but to restore neuronal communication.
The history of medicine consists of small victories against the impossible. Just a few decades ago, the idea of curing a stroke-damaged brain would have been unthinkable, yet today it is a reality.
